Effects of Empagliflozin on Cardiorespiratory Fitness and Significant Interaction of Loop Diuretics

INTRODUCTION: The effects of empagliflozin on cardiorespiratory fitness in patients with type 2 diabetes mellitus (T2DM) and heart failure with reduced ejection fraction (HFrEF) are unknown. METHODS: In this pilot study we determined the effects of empagliflozin10 mg/day for four weeks on peak oxyge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Carbone, Salvatore, Canada, Justin M, Billingsley, Hayley E, Kadariya, Dinesh, Dixon, Dave L, Trankle, Cory R, Buckley, Leo F, Markley, Roshanak, Vo, Chau, de Chazal, Horacio Medina, Christopher, Sanah, Buzzetti, Raffaella, Van Tassell, Benjamin W, Abbate, Antonio
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6043379/
https://ncbi.nlm.nih.gov/pubmed/29603546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13309
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados